According to Milestone Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 85.0397. At the end of 2023 the company had a P/S ratio of 55.9.
Year | P/S ratio | Change |
---|---|---|
2023 | 55.9 | 105.92% |
2022 | 27.2 | 108.17% |
2021 | 13.0 | |
2020 | N/A | |
2019 | N/A |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |